Health Care & Hospital Law
May 18, 2023
Los Angeles attorney appointed to co-lead Zantac cancer cases in Delaware
More than 77,000 people have sued GSK plc, formerly GlaxoSmithKline plc, in Delaware state court. They allege that the ulcer drug Zantac contains a known carcinogen called N-nitrosodimethylamine (NDMA).
R. Brent Wisner, the managing partner of the Los Angeles law firm Wisner Baum, was appointed plaintiffs’ leadership counsel in the Zantac liability litigation in Delaware Superior Court.
“The formation of a new venue for these cases creates more opportunity for our clients and other people throughout the country stricken with cancer after taking a drug that we believe is dangerous,” Wisner said. “We look forward to presenting evidence at t...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In